NCT05779553View on ClinicalTrials.gov

Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

December 31, 2026

Conditions
Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits

measurement of serum TEM1 in CRC patients, its relation to staging and comparing the diagnostic performance of serum TEM1 with serum CEA and CA19-9 for diagnosis of CRC. and Early detection of CRC patient

All Listed Sponsors
lead

Assiut University

OTHER

NCT05779553 - Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression | Biotech Hunter | Biotech Hunter